Fecal Transplant +/- Gut Decontamination in Preventing Acute Graft Versus Host Disease in Patients Given Broad-Spectrum Antibiotics
NCT03862079 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2020-03-04
Summary
This phase II trial studies how well a fecal microbiota transplant with or without total gut decontamination works in preventing graft versus host disease in patients exposed to broad-spectrum antibiotics. Fecal microbiota transplantation is the administration by enema of fecal matter (stool) that includes helpful bacteria from a normal, healthy donor. Total gut decontamination uses antibiotics to remove/reduce the amount of bacteria in the digestive system. It is not yet known if a fecal microbiota transplant with or without total gut decontamination works better in preventing graft versus host disease compared to standard immunosuppressive therapies (therapies that lower the normal function of the immune system).
Conditions
- Graft-versus-host Disease Prevention
Interventions
- OTHER
-
Best Practice
Given standard of care
- PROCEDURE
-
Fecal Microbiota Transplantation
Undergo FMT
- DRUG
-
Nystatin
Given PO
- DRUG
-
Piperacillin-Tazobactam
Given PO
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Amin M Alousi · M.D. Anderson Cancer Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 16 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-01
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
NCT02269150 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
The Effect of Faecal Microbiota Transplantation (FMT) on Eradication of Multidrug Resistant Organisms (MRO) in Intestinal Carriers
NCT05742074 ·Status: COMPLETED ·Phase: NA
-
Fecal Microbiota Transplant (FMT) Plus Fidaxomicin for Severe or Fulminant Clostridium Difficile Infection
NCT03760484 ·Status: TERMINATED ·Phase: PHASE2
-
Eradication of Antibiotic-resistant Bacteria Through Antibiotics and Fecal Bacteriotherapy
NCT02472600 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy of Fecal Microbiome Transplantation (FMT) in the Treatment of Antibiotic Dependent Pouchitis (ADP)
NCT02782325 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation
NCT03621657 ·Status: COMPLETED ·Phase: PHASE2
-
Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection
NCT03806803 ·Status: COMPLETED ·Phase: PHASE2
-
Autologous Fecal Therapy
NCT02046525 ·Status: COMPLETED ·Phase: PHASE2
-
Fecal Microbiota Transplantation for Decolonization of Multidrug-resistant Microorganisms
NCT07265817 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Intestinal Microbiota Transplantation in Patients Undergoing Colon Resection
NCT06370884 ·Status: RECRUITING ·Phase: PHASE1
-
Fecal Microbiota Transplant for Relapsing Clostridium Difficile Infection in Adults and Children Using a Frozen Encapsulated Inoculum
NCT01914731 ·Status: COMPLETED ·Phase: PHASE1
-
Fecal Microbiota Transplantation for Severe Clostridium Difficile Infection
NCT03427229 ·Status: COMPLETED ·Phase: PHASE2
-
FMT for Multidrug Resistant Organism Reversal
NCT02312986 ·Status: COMPLETED ·Phase: PHASE1
-
Fecal Microbiota Transplantation to Treat Recurrent C. Difficile Associated Diarrhea Via Retention Enema or Oral Route
NCT02449174 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients
NCT03617445 ·Status: TERMINATED ·Phase: PHASE2
-
Fecal Microbiota Transplantation for Eradication of Carbapenem-resistant Enterobacteriaceae Colonization
NCT03391674 ·Status: WITHDRAWN ·Phase: NA
-
Fecal Microbiota Transplantation for Treatment of Gastrointestinal Dysbiosis or Clearance of ARO
NCT03834051 ·Status: TERMINATED ·Phase: NA
-
Fecal Microbiota Transplant
NCT04090346 ·Status: COMPLETED ·Phase: PHASE4
-
Fecal Microbiota Transplant (FMT) for Relapsing C. Difficile Infection in Adults and Children Using a Frozen Inoculum
NCT01704937 ·Status: COMPLETED ·Phase: PHASE1
-
Fecal Microbiota Transplantation for Steroid Resistant/Dependent Acute GI GVHD
NCT03812705 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of Encapsulated Fecal Microbiota for Vancomycin Resistant Enterococcus Decolonization
NCT03063437 ·Status: COMPLETED ·Phase: PHASE2
-
Fecal Transplant for MDRO Decolonization
NCT04181112 ·Status: UNKNOWN ·Phase: NA
-
Fecal Microbiota Transplantation for Primary Clostridium Difficile Diarrhea
NCT02801656 ·Status: WITHDRAWN ·Phase: PHASE3
-
Penn Microbiome Therapy (PMT) for Severe-Clostridium Difficile Infection (CDI)
NCT03970200 ·Status: TERMINATED ·Phase: PHASE2
-
Fecal Microbiota Transplant for Patients With Chronic Pouchitis
NCT05829109 ·Status: RECRUITING ·Phase: EARLY_PHASE1